SAVA has 36-month beta value of -0.63. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for SAVA is 42.38M, and currently, short sellers hold a 41.59% ratio of that float. The average trading volume of SAVA on October 24, 2024 was 2.64M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SAVA) stock’s latest price update
The stock price of Cassava Sciences Inc (NASDAQ: SAVA) has dropped by -1.55 compared to previous close of 28.43. Despite this, the company has seen a fall of -5.53% in its stock price over the last five trading days. zacks.com reported 2024-09-30 that Casava stock falls as the company agrees to pay a cumulative fine exceeding $40 million to settle misleading claims charges brought against it by the SEC.
SAVA’s Market Performance
SAVA’s stock has fallen by -5.53% in the past week, with a monthly drop of -5.38% and a quarterly rise of 119.53%. The volatility ratio for the week is 4.95% while the volatility levels for the last 30 days are 8.06% for Cassava Sciences Inc. The simple moving average for the past 20 days is 0.94% for SAVA’s stock, with a 22.91% simple moving average for the past 200 days.
Analysts’ Opinion of SAVA
Many brokerage firms have already submitted their reports for SAVA stocks, with H.C. Wainwright repeating the rating for SAVA by listing it as a “Buy.” The predicted price for SAVA in the upcoming period, according to H.C. Wainwright is $116 based on the research report published on October 08, 2024 of the current year 2024.
B. Riley Securities gave a rating of “Neutral” to SAVA, setting the target price at $44 in the report published on November 16th of the previous year.
SAVA Trading at -1.36% from the 50-Day Moving Average
After a stumble in the market that brought SAVA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.67% of loss for the given period.
Volatility was left at 8.06%, however, over the last 30 days, the volatility rate increased by 4.95%, as shares sank -8.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +17.16% upper at present.
During the last 5 trading sessions, SAVA fell by -5.53%, which changed the moving average for the period of 200-days by +15.28% in comparison to the 20-day moving average, which settled at $27.73. In addition, Cassava Sciences Inc saw 24.34% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for SAVA
Current profitability levels for the company are sitting at:
- -58.69 for the present operating margin
- 0.42 for the gross margin
The net margin for Cassava Sciences Inc stands at -6.55. The total capital return value is set at -0.73. Equity return is now at value -8.35, with -6.97 for asset returns.
Currently, EBITDA for the company is -104.43 million with net debt to EBITDA at 1.51. When we switch over and look at the enterprise to sales, we see a ratio of 483.63. The receivables turnover for the company is 1.63for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.07.
Conclusion
To put it simply, Cassava Sciences Inc (SAVA) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
